IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 165 filers reported holding IMPAX LABORATORIES INC in Q4 2013. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $191,000 | -63.3% | 15,161 | -61.5% | 0.00% | -100.0% |
| Q4 2016 | $521,000 | -46.8% | 39,336 | -4.8% | 0.00% | -50.0% |
| Q3 2016 | $979,000 | -95.6% | 41,321 | -94.7% | 0.00% | -96.4% |
| Q2 2016 | $22,455,000 | +2.2% | 779,156 | +13.5% | 0.06% | +5.8% |
| Q1 2016 | $21,978,000 | +101.0% | 686,377 | +168.4% | 0.05% | +108.0% |
| Q4 2015 | $10,935,000 | +20.7% | 255,732 | -0.6% | 0.02% | +25.0% |
| Q3 2015 | $9,058,000 | -26.4% | 257,255 | -4.0% | 0.02% | -20.0% |
| Q2 2015 | $12,307,000 | -43.5% | 268,003 | -42.3% | 0.02% | -41.9% |
| Q1 2015 | $21,788,000 | +11.4% | 464,862 | -24.7% | 0.04% | +7.5% |
| Q4 2014 | $19,555,000 | -1.9% | 617,285 | -26.6% | 0.04% | -4.8% |
| Q3 2014 | $19,926,000 | +38.3% | 840,440 | +74.9% | 0.04% | +35.5% |
| Q2 2014 | $14,410,000 | +11.9% | 480,488 | -1.4% | 0.03% | +6.9% |
| Q1 2014 | $12,879,000 | +440.7% | 487,495 | +414.5% | 0.03% | +383.3% |
| Q4 2013 | $2,382,000 | – | 94,749 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 560,400 | $9,022,000 | 3.93% |
| NORTH TIDE CAPITAL, LLC | 1,000,000 | $16,100,000 | 3.58% |
| Sivik Global Healthcare LLC | 250,000 | $4,025,000 | 1.47% |
| MAVERICK CAPITAL LTD | 7,159,336 | $115,265,000 | 1.44% |
| SECTOR GAMMA AS | 589,311 | $9,488,000 | 1.38% |
| BRIDGER MANAGEMENT, LLC | 1,341,143 | $21,592,000 | 1.23% |
| Eos Focused Equity Management, L.P. | 48,714 | $784,000 | 0.89% |
| Bridge City Capital, LLC | 47,194 | $760,000 | 0.64% |
| Fosun International Ltd | 300,000 | $4,830,000 | 0.60% |
| Century Capital Management, LLC | 203,138 | $3,271,000 | 0.56% |